JPWO2023069888A5 - - Google Patents

Info

Publication number
JPWO2023069888A5
JPWO2023069888A5 JP2024522646A JP2024522646A JPWO2023069888A5 JP WO2023069888 A5 JPWO2023069888 A5 JP WO2023069888A5 JP 2024522646 A JP2024522646 A JP 2024522646A JP 2024522646 A JP2024522646 A JP 2024522646A JP WO2023069888 A5 JPWO2023069888 A5 JP WO2023069888A5
Authority
JP
Japan
Prior art keywords
seq
nos
heavy chain
light chain
chain seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024522646A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024538148A5 (https=
JP2024538148A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/078192 external-priority patent/WO2023069888A1/en
Publication of JP2024538148A publication Critical patent/JP2024538148A/ja
Publication of JP2024538148A5 publication Critical patent/JP2024538148A5/ja
Publication of JPWO2023069888A5 publication Critical patent/JPWO2023069888A5/ja
Pending legal-status Critical Current

Links

JP2024522646A 2021-10-18 2022-10-17 抗ＥＧＦＲ抗体、抗ｃＭＥＴ抗体、抗ＶＥＧＦ抗体、多重特異性抗体及びそれらの使用 Pending JP2024538148A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163256705P 2021-10-18 2021-10-18
US63/256,705 2021-10-18
PCT/US2022/078192 WO2023069888A1 (en) 2021-10-18 2022-10-17 ANTI-EGFR ANTIBODIES, ANTI-cMET ANTIBODIES, ANTI-VEGF ANTIBODIES, MULTISPECIFIC ANTIBODIES, AND USES THEREOF

Publications (3)

Publication Number Publication Date
JP2024538148A JP2024538148A (ja) 2024-10-18
JP2024538148A5 JP2024538148A5 (https=) 2025-10-22
JPWO2023069888A5 true JPWO2023069888A5 (https=) 2025-10-22

Family

ID=84267971

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024522646A Pending JP2024538148A (ja) 2021-10-18 2022-10-17 抗ＥＧＦＲ抗体、抗ｃＭＥＴ抗体、抗ＶＥＧＦ抗体、多重特異性抗体及びそれらの使用

Country Status (8)

Country Link
US (1) US20250230248A1 (https=)
EP (1) EP4419556A1 (https=)
JP (1) JP2024538148A (https=)
KR (1) KR20240099227A (https=)
CN (1) CN118355030A (https=)
AU (1) AU2022369278A1 (https=)
CA (1) CA3232216A1 (https=)
WO (1) WO2023069888A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4454705A1 (en) * 2023-04-28 2024-10-30 Jost B. Jonas Egfr antagonists for the treatment of diseases involving unwanted migration, proliferation, and metaplasia of retinal pigment epithelium (rpe) cells
WO2025056713A1 (en) * 2023-09-12 2025-03-20 Jonas Jost B Egfr antagonists for the treatment of diseases involving unwanted migration, proliferation, and/or metaplasia of retinal pigment epithelium (rpe) cells
WO2025108427A1 (zh) * 2023-11-23 2025-05-30 橙帆生物医药公司 结合分子及抗体药物偶联物和用途
CN118085101A (zh) * 2024-03-01 2024-05-28 烟台蓝纳成生物技术有限公司 一种二价双特异性抗体、抗体偶联核素药物及其应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
ATE87659T1 (de) 1986-09-02 1993-04-15 Enzon Lab Inc Bindungsmolekuele mit einzelpolypeptidkette.
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
ATE199392T1 (de) 1992-12-04 2001-03-15 Medical Res Council Multivalente und multispezifische bindungsproteine, deren herstellung und verwendung
AUPO591797A0 (en) 1997-03-27 1997-04-24 Commonwealth Scientific And Industrial Research Organisation High avidity polyvalent and polyspecific reagents
EP1789446A2 (en) 2004-09-02 2007-05-30 Genentech, Inc. Heteromultimeric molecules
EP3050963B1 (en) 2005-03-31 2019-09-18 Chugai Seiyaku Kabushiki Kaisha Process for production of polypeptide by regulation of assembly
DE102005028778A1 (de) 2005-06-22 2006-12-28 SUNJÜT Deutschland GmbH Mehrlagige Folie mit einer Barriere- und einer antistatischen Lage
EP1934259A2 (en) * 2005-10-11 2008-06-25 Ablynx N.V. Nanobodies and polypeptides against egfr and igf-ir
WO2007147901A1 (en) 2006-06-22 2007-12-27 Novo Nordisk A/S Production of bispecific antibodies
BRPI1014449A2 (pt) 2009-04-07 2017-06-27 Roche Glycart Ag anticorpos biespecíficos anti-erbb-2/ anti-c-met.
JP2012525149A (ja) 2009-04-27 2012-10-22 オンコメッド ファーマシューティカルズ インコーポレイテッド ヘテロ多量体分子を作製するための方法
CN103889451B (zh) * 2011-09-30 2016-06-29 埃博灵克斯股份有限公司 与C-Met相关的生物物质
CN113201073A (zh) * 2012-11-21 2021-08-03 詹森生物科技公司 双特异性EGFR/c-Met抗体
US20170275367A1 (en) 2012-11-21 2017-09-28 Janssen Biotech, Inc. Bispecific EGFR/C-Met Antibodies
KR102089591B1 (ko) 2013-07-29 2020-03-18 삼성전자주식회사 항 EGFR scFv 단편 및 이를 포함하는 항 c-Met/항 EGFR 이중 특이 항체
HUE046936T2 (hu) 2014-11-27 2020-04-28 Panasonic Ip Man Co Ltd Üvegtábla-egység
CN108350078A (zh) 2015-11-03 2018-07-31 默克专利股份公司 用于提高肿瘤选择性和抑制的双特异性抗体及其用途

Similar Documents

Publication Publication Date Title
CN107922503B (zh) 一种pdl-1抗体、其药物组合物及其用途
JP2021514664A5 (https=)
IL302078A (en) Anti-CCR8 monoclonal antibodies and their uses
JP2021526022A5 (https=)
IL276830B1 (en) Anti-claudin 18.2 antibodies and their uses
KR102078292B1 (ko) 신규한 항 c-Met 항체 및 이의 용도
JP2020079252A5 (https=)
JPWO2019173291A5 (https=)
JP2017514461A5 (https=)
JP2017529838A5 (https=)
CN114761433B (zh) 一种抗Claudin18.2单克隆抗体、其制备方法及用途
RU2009129403A (ru) Антитела, нейтрализующие цитомегаловирус человека, и их применение
HRP20192038T1 (hr) Protutijela receptora anti-epidermalnog faktora rasta (egfr)
US20250179195A1 (en) Anti-flt3 antibodies and compositions
JP2020522281A5 (https=)
JP2017521054A5 (https=)
JPWO2020198009A5 (https=)
JP2024024114A5 (https=)
JP2021517459A5 (https=)
JP2021531732A5 (https=)
JP2021518390A5 (https=)
JP2018528759A5 (https=)
JPWO2023020621A5 (https=)
JPWO2023069888A5 (https=)
TW202108631A (zh) 一種抗ｃｄ４７抗原結合蛋白及其應用